These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23677008)

  • 21. Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases.
    Shelton CD; Byndloss MX
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32122941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine.
    Maier E; Anderson RC; Roy NC
    Nutrients; 2014 Dec; 7(1):45-73. PubMed ID: 25545102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The resilience of the intestinal microbiota influences health and disease.
    Sommer F; Anderson JM; Bharti R; Raes J; Rosenstiel P
    Nat Rev Microbiol; 2017 Oct; 15(10):630-638. PubMed ID: 28626231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.
    Shimizu H; Arai K; Asahara T; Takahashi T; Tsuji H; Matsumoto S; Takeuchi I; Kyodo R; Yamashiro Y
    BMC Microbiol; 2021 Oct; 21(1):275. PubMed ID: 34627158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highlights on two decades with microbiota and inflammatory bowel disease from etiology to therapy.
    Hajj Hussein I; Dosh L; Al Qassab M; Jurjus R; El Masri J; Abi Nader C; Rappa F; Leone A; Jurjus A
    Transpl Immunol; 2023 Jun; 78():101835. PubMed ID: 37030558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection.
    Sokol H; Jegou S; McQuitty C; Straub M; Leducq V; Landman C; Kirchgesner J; Le Gall G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Richard ML; Beaugerie L
    Gut Microbes; 2018 Jan; 9(1):55-60. PubMed ID: 28786749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammatory bowel diseases and enteric microbiota].
    Kim JM
    Korean J Gastroenterol; 2010 Jan; 55(1):4-18. PubMed ID: 20098062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxygen as a driver of gut dysbiosis.
    Rivera-Chávez F; Lopez CA; Bäumler AJ
    Free Radic Biol Med; 2017 Apr; 105():93-101. PubMed ID: 27677568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut biofilm forming bacteria in inflammatory bowel disease.
    Srivastava A; Gupta J; Kumar S; Kumar A
    Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?
    Burman S; Hoedt EC; Pottenger S; Mohd-Najman NS; Ó Cuív P; Morrison M
    Dig Dis; 2016; 34(1-2):64-71. PubMed ID: 26982568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.
    Said HS; Suda W; Nakagome S; Chinen H; Oshima K; Kim S; Kimura R; Iraha A; Ishida H; Fujita J; Mano S; Morita H; Dohi T; Oota H; Hattori M
    DNA Res; 2014 Feb; 21(1):15-25. PubMed ID: 24013298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.